VR

Vicky Rawat

Active Director Director DIN 08923772
DIN 08923772 First appointment Nov 2020 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2020
Shareholding value Locked Premium profile

About Vicky Rawat

Vicky Rawat has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Pfizeneca Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08923772
Primary Designation Director
First Appointment 09 Nov 2020
Oldest Company Age 9 yrs

Current companies

Company Designation Appointment Founded Status
Director 09 Nov 2020 2017 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pfizeneca Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vicky Rawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vicky Rawat

Vicky Rawat has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Pfizeneca Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Vicky Rawat is associated with 1 company as Director.

Vicky Rawat has expertise in General Business.

Vicky Rawat has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available